We’re CLEAR Foundation, or Canadians for Leading Edge Alzheimer Research, because that’s exactly what we are. We’re on a mission to eradicate all forms of dementia, including Alzheimer disease.

A tidal wave of dementia diagnoses is on the horizon, and the best way to spare future generations the devastation of this disease is to get rid of it once and for all. And the only way to do that is through research. CLEAR is the only Canadian foundation that directs 100% of funds raised to promising scientific research into the cause, prevention, and treatment of Alzheimer Disease and other dementias.

The research we fund with Michael Smith Health Research BC could lead to the breakthrough the world has been waiting for, here in Canada or somewhere else in the world. In the global fight against this unforgiving disease, we’re all in this together.

Note: CLEAR Foundation was formerly known as the Pacific Alzheimer Research Foundation (PARF).

Funding interests

Award types

Research Trainee, Scholar


Research interests

CLEAR (Canadians for Leading edge Alzheimer Research) Foundation is interested in supporting biomedical (and clinical) research to increase understanding of the evolution of Alzheimer disease and related dementias (ADRD) enabling discovery of disease mitigating treatment and one day a cure.

  • Alzheimer and related disorders (ADRD)
  • neurodegeneration
  • Alzheimer prevention
  • Alzheimer cause
  • Alzheimer treatment
  • Alzheimer cure

Awards

2023

Recipient

Amanda Orr

Award type

Research trainee award


Project title

3D bioprinting patient-derived neural tissues for screening potential treatments for
Alzheimer’s disease

Recipient

Manu Madhav

Award type

Scholar award


Project title

Quantifying navigational impairments in preclinical Alzheimer’s disease

2022

Recipient

Jordan Hamden

Award type

Research Trainee award


Project title

In vitro diagnostics for frontotemporal dementia

Recipient

Michael Adachi

Award type

Scholar award


Project title

Developing sensors for rapid detection of biomarker proteins for Alzheimer’s disease

2020


Award type

Research Trainee award


Project title

Resisting Vascular Cognitive Impairment: The Effects of Resistance Training on Myelin and Blood-based Biomarkers of Neuroplasticity in Older Adults

Recipient

Katherine Elvira

Award type

Scholar award


Project title

Building bespoke artificial cells and tissues on a chip for drug discovery

2017

Recipient

Dustin King

Award type

Research Trainee award


Project title

Elucidating the effect of O-GlcNAc modification on protein stability

2016

Recipient

Arya Mehran

Award type

Research Trainee award


Project title

Neurally-produced estradiol enhances the neuroprotective actions of insulin

Recipient

Haakon Nygaard

Award type

Scholar award


Project title

Chemical suppression of nonsense mutations for the treatment of Frontotemporal Dementia

2015

Recipient

Vedrana Cvetkovska

Award type

Research Trainee Award


Project title

The mechanism and significance of the synaptogenic activity of amyloid precursor protein

Recipient

Jasmin Hefendehl

Award type

Research Trainee Award


Project title

Altered glutamate dynamics in a mouse model of Alzheimer’s disease: Novel early biomarkers with therapeutic potential

Recipient

Yun Zhang

Award type

Research Trainee Award


Project title

Human islet amyloid polypeptide aggregation, the missing link between type 2 diabetes and Alzheimer’s disease?

Recipient

Sieun Lee

Award type

Research Trainee Award


Project title

Are there indicators of Alzheimer’s disease in the eye?: New computational imaging and analysis algorithms

Recipient

David Vocadlo

Award type

British Columbia Alzheimer’s Research Award


Project title

Preclinical development of a disease modifying small molecule therapy for Alzheimer disease

Recipient

James Johnson

Award type

British Columbia Alzheimer’s Research Award


Project title

Locally produced brain insulin in memory and Alzheimer’s disease: A multi-disciplinary approach to a key question

Recipient

Christian Naus

Award type

British Columbia Alzheimer’s Research Award


Project title

Validation of connexins and pannexins as a target for Alzheimer’s disease

Recipient

Faisal Beg

Award type

British Columbia Alzheimer’s Research Award


Project title

Novel retinal biomarkers for Alzheimer’s disease

2013

Recipient

Neil Cashman

Award type

British Columbia Alzheimer’s Research Award


Project title

Targeting amyloid propagation in Alzheimer disease: Structures, immunology and extracellular vesicle topology